Neuromyelitis optica spectrum disorders: Comparison according to the phenotype and serostatus
about
Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases.Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response.Short segment myelitis as a first manifestation of neuromyelitis optica spectrum disorders.Postinfectious Anti-Myelin Oligodendrocyte Glycoprotein Antibody Positive Optic Neuritis and Myelitis.A box of chocolatesDiffusion tensor imaging for multilevel assessment of the visual pathway: possibilities for personalized outcome prediction in autoimmune disorders of the central nervous system.Pattern Recognition of the Multiple Sclerosis Syndrome.Liver injury and glatiramer acetate, an uncommon association: case report and literature review.Immunopathogenesis in Myasthenia Gravis and Neuromyelitis Optica.Disease Course and Treatment Responses in Children With Relapsing Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.Epidemiology of NMOSD in Catalonia: Influence of the new 2015 criteria in incidence and prevalence estimates.Combined brain and anterior visual pathways' MRIs assist in early identification of neuromyelitis optica spectrum disorder at onset of optic neuritis.Mechanisms for lesion localization in neuromyelitis optica spectrum disorders.Clinical profile of patients with paraneoplastic neuromyelitis optica spectrum disorder and aquaporin-4 antibodies.Defining distinct features of anti-MOG antibody associated central nervous system demyelination.Optical coherence tomography in neuromyelitis optica spectrum disorders: potential advantages for individualized monitoring of progression and therapy.MOG-IgG-Associated Optic Neuritis, Encephalitis, and Myelitis: Lessons Learned From Neuromyelitis Optica Spectrum Disorder.Diagnosis and Treatment of NMO Spectrum Disorder and MOG-EncephalomyelitisObjective assessment of a relative afferent pupillary defect by B-mode ultrasound
P2860
Q33645795-1B3DC16C-676D-43A7-B73F-DBC2413C3C0DQ38750021-D35587EA-D473-4BD1-BA6F-3889C3CCE590Q39076645-BA8E1BFE-594D-46C8-9EB3-25499A1110A5Q40042836-1D66D3FB-6FDC-4EDA-8A0A-D5C20D9134CEQ42158685-49CF6673-B211-4647-A6F1-1A8464B93AC0Q42361527-D5202428-5CD7-4BB9-BF19-FFD3248EE6E6Q47096340-2A31F45F-BCE6-40EA-9E94-7D1289ECF72CQ47097362-B890A140-F6A0-40CA-BE7C-EE63B11D70CCQ47192132-E42202CE-C181-4198-A61B-35878B9D5A05Q47203404-291B981B-9D6A-4D69-9C95-2A1DCA5DE409Q47618323-018F3844-7436-46C2-BF8A-8B7EED2C5DCBQ48445648-CC7A945D-000D-4F0A-9A1A-2EA9CBEC91A2Q49713173-E8D9EDEC-D27F-45B2-B67A-CFC3532D4623Q50048448-95A2030F-AF5C-4B8B-A954-2BBDC878F625Q52603606-CDA5C90D-4036-4DBB-8827-4A2434CBCCF8Q52668258-A6C4252B-F861-4744-8EE1-EA81914933E8Q55221002-E1D64348-9195-4138-BAC5-E95A4643D8F3Q58573155-72B71EA1-D48B-4B87-930E-E210A826FC63Q58701679-754AC519-9FDE-4D23-8109-36C1ECD2229B
P2860
Neuromyelitis optica spectrum disorders: Comparison according to the phenotype and serostatus
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Neuromyelitis optica spectrum ...... o the phenotype and serostatus
@en
type
label
Neuromyelitis optica spectrum ...... o the phenotype and serostatus
@en
prefLabel
Neuromyelitis optica spectrum ...... o the phenotype and serostatus
@en
P2093
P2860
P50
P1476
Neuromyelitis optica spectrum ...... o the phenotype and serostatus
@en
P2093
Adolfo Jiménez-Huete
Albert Saiz
Alfredo R Antigüedad
Amaya Alvarez de Arcaya
Ana Caminero
Angeles Cervelló
Bonaventura Casanova
Carmen Calles
Celia Oreja-Guevara
Clara de Andrés
P2860
P356
10.1212/NXI.0000000000000225
P50
P577
2016-04-14T00:00:00Z